3d wound detection & tracking system powered by …€¦ · specialized in cloud infrastructure...

3 D W O U ND D ET EC T I O N & T RAC K I NG SY ST EMP O W ERED BY ART I F I C I AL I NT EL L I G ENC E *

*COVERED BY PATENT

WOUND VIEWERWOUND VIEWER

Chronic

CHRONIC

2


Chronic wounds affect over 2% of the worldwide population

10MILLIO N

PAT IE NT SChronic skin wounds$ 40 BILL IO NEXPENSEin Europe

2% OF WORLD WIDE POPULATION IS AFFECTEDBY CHRONIC ULCERS

SOURCE: HTTP://www.BRHMEDICAL. COM/ECONOMICS-OF-WOUND-CARE


Wound measurement and monitoring are essential for healing

If an ulcer does not improve in the f i r s t 4 weeks:

70% 32% 50%NEVERHEALING

RISK OFAMPUTATION**

MORTALITY IN CASEOF AMPUTATION** *

4 * HTTP S :// WWW.NCBI.NLM. NIH. GOV/PUBMED/12766127

AN ACCURATE WOUND ASSESSMENT IN THE FIRST 4WEEKS IS CRUCIAL*


Current standard of practice presents plenty of room for improvement

RUDIMENTAL &INACCURATE

40% ERROR PAINFUL DATA LOSS 20 MINUTES

INVASIVEAND

STORAGE IN PAPERFOLDERS

TIMECONSUMING


Our Click-and-Go mobile solution: the Wound Viewer

94% ACCURACY(+/- 4%)

*"DISPOS IT IVO E PROCEDIMENTO DI ACQUIS IZ IONE DI IMMAGINI MEDICHE PER L' ANAL IS I DI ULCERE" ( ITUB20159560) - (PCT/IB2016/057868 )

AI Algorithm WV Device MobileAPP

CloudPlatform

PATIENTS

CLICK AND GO MOBILE SOLUTION

PATENTEDEPO & US(Extended)

5TRIALED ON


Faster, more accurate and easier to use than the competition

Monitoring completeness

Easy

to u

se

MALVIS III

Wound Viewer

In-sight

I:X - MoleculightWound MappingUltrasound

Wound SmartVisitrak

Silouhette

EPISCAN I-200

Wound Matrix

Parable Health

Wound Desk

MoWa

Scout

TissueAnalytics

Wound Right

Mobile App Traditional systems Next-gen device

The Next-gen device wound Monitoring market is growing fast (CAGR +20%) and it is very fragmented (tens of player with nodominant standard). The biggest player is Aranz Medical (Silouhette) which has a turnover of 15 M $


Wound Viewer is able to provides standardized wound assessments deliveringcompelling value propositions for hospitals and pharma company

*Case based on a 700 bed hospital ** Case based on Financial analysis on Smith and Nephew after the partnership with Moleculight (2017)

+1M €/YEAR SAVINGS /INCREASED REVENUES PER

HOSPITAL*

HOSPITAL & CLINICS WOUND-CARE PHARMA

Reduction of hospitalizations enabling homecare management

Care optimization, resulting in reduced waste ofdisposables (e.g. bandages)

Reduction of the risk of legal litigation by 20% Increment of the inpatient-to-outpatient

turnover by 30%

Product Bundling with the existing productportfolio for increasing sales revenues

Reduction of the risk of failure forclinical trials Phase III and/or Phase IV

Standardized and certified quantitativeclinical data

Up to+190M €/YEARINCREASED SALES

REVENUES * *


At the moment we are proving what we are promising and we are getting to scale-up

6 month follow-up trial, multicenter, ASL TO3 – ASL2 AstiWhat is ongoing:

CERTIFIED CLINICALTRIALS APPROVED BYETHICAL COMMITTEE

Protocol: 0C 15194, 3 October 2017

Starting date: February 2018

Number patients enrolled: 150

• Integration of Wound Viewertechnology with Dedalus S.p.Awoundcare system

• The integrated product will betested through a Multicentricclinical trial with ASL TO 3 andASL 2 Asti

• The multicentric clinical trial isdesigned to prove thefollowing endpoints:

– Standardize woundclassification

– Hospital cost reductionon wound care

– Scalability of thesolution throught theintegration with Dedalussystems


Thanks to a supporting ecosystem of universities, medical practices and suppliers


Backed by clinical, strategic and scientific advisors

EMILIO PAOLUCCIVICE DEAN FOR TECHNOLOGY TRANSFER- POLITECNICO DI TORINO

CO- FOUNDER OF ELECTRO POWER

SYSTEMS ( EPS), COMPANY CURRENTLYLISTED ON PARIS STOCKS EXCHANGE

JASON SAKAMOTO

OWNER OF “MINUS NINE” CONSU LTING FIRMBASED IN HOUSTON, TEXAS

CHAIRMAN OF THE NANOMEDICINEDEPARTMENT OF THE HOUSTON METHODISTRESEARCH INSTITUTE

DANILO DEMARCHIASSOCIATE PROFESSOR,DEPARTMENT OF ELECTRONICSAND TELECOMMUNICATION (DET) -POLITECNICO DI TORINO

CLINICAL & STRATEGIC ADVISORS SCIENTIFIC ADVISORS

ELIA RICCISURGEON AND CHAIRMAN OF THE WOUNDDEPARTMENT OF CLINICA S. LUCA TORINO

CO- FOUNDER OF THE ITALIAN ASSOCIATIONOF CUTANEOUS ULCERS (AIUC)

FERNANDO CORINTOASSOCIATE PROFESSOR,DEPARTMENT OF ELECTRONICSAND TELECOMMUNICATION ( DET)- POLITECNICO DI TORINO


Delivered by a multidisciplinary team

UBALDO UBERTIMS INFORMATICSFORMER CTO OF DE AGOSTINIGROUPSPECIALIZED IN CLOUDINFRASTRUCTURE

VITO MUSCIMBA , MA STATISTICS,MS AEROSPACE ENGINEERINGSPECIALIZED IN BUSINESSDEVELOPMENT AND DATAANALYTICS

MATTEO D’OSPINAM. SC IN INFORMATICSENGINEERING

SPECIALIZED IN APP DESIGN

PIERGIORGIO PEROTTOJD, LAWYER

SPECIALIZED IN PRIVACYAND MEDICAL REGULATIONS

ALBERTO UBERTIMBA, MS MANAGEMENTENGINEERING

SPECIALIZED IN CYBER SECURITY,DATA GOVERNANCE ANDBUSINESS DEVELOPMENT

JACOPO SECCOPHD ELECTRONIC ENGINEERINGMS BIOMEDICAL ENGINEERING ,

MBA ,SPECIALIZED IN BIG DATA,AI AND MACHINE LEARNING ALGORITHMSAND CLINICAL PROCEDURES

PARIDE LETIZIAM. SC IN INFORMATICS ENGINEERINGMBA

SPECIALIZED IN SOFTWAREARCHITECTURE AND SOFTWAREDEVELOPMENT LIFE CYCLE

MARCO FARINAPHD ELECTRONIC ENGINEERINGMS BIOMEDICAL ENGINEERINGSPECIALIZED IN AI, DEVELOPMENTOF MEDICAL DEVICES ANDCE/FDAREGULATION


To reach interesting addressable markets

2 Patent filing andPCT extension

Product and servicedevelopment

Certified monocentricclinical trials withMinistry of Health

Worldwide patentsextension

Multicenter clinical trials toprove that Wound Viewer:

1. Has a standardizedwound classification

2. Is scalable and repeatable(can be applied in everyhospital)

3. Offers a proved Hospitalcost reduction

Total Addressable Market:140.000.000 €*

Partnership with woundtreatment manufacturer

Proven standardized woundmeasurement

Total Addressable Market:750.000.000 €**

PHASE 0

INDIRECT SALES THROUGHSYSTEM INTEGRATOR

2018 - 2020

WOUND CARE PRODUCTAND SERVICE BUNDLING

2021-2022

PHASE 1 PHASE 2

Partnership with ADI (IntegratedHome Care) provider: Vivisol

+ 100 K€ collected (awards,grant and fundings)

New functionalities on theWound Viewer andimprovement on algorithms

Bundle-sale agreement withwound care productmanufacturer or serviceproviders

* 350.000 € project for territory system * 400 regions

Partnership with hospitalsystem integrator: Dedalus

System delivery to first hospitalusers (AL3 To, ASL2 Asti)

PRODUCT AND IPDEVELOPMENT

Q1 2016 – Q2 2018

** Proxy valuation based on Moleculight - Smith & Nephew agreement

Jacopo Secco (CEO) & Alberto Uberti (COO)Omnidermal SRL

[email protected]

3d wound detection & tracking system powered by …€¦ · specialized in cloud infrastructure...

Documents